Navigation Links
Human in Biological Technology

Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody

... a series of published experiments using primary human tumors in xenograft models, OncoMed scientists ... models, using xenografts established from primary human tumors. These models are designed to be more directly representative of human tumors than the cell lines used in standard ...

Transposagen Creates a Rat Model of the Human Immune System

... mice for specific disease categories including human cardiovascular disease, diabetes, arthritis, and ... models with single gene disruptions that mimic human diseases. Transposagen's goal is to produce ... modified rat models. These models mimic human diseases and are used for drug discovery and ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... platform to the treatment of a broad range of human genetic diseases. As part of this effort, Amicus ... entered into a strategic collaboration with Shire human Genetic Therapies, Inc., a wholly-owned ... chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone ...

GeoVax Labs, Inc. Provides Clinical Studies Update

... announced updates on its ongoing and planned human clinical trials. "We have two main areas ... to move up to another level of analysis, Phase 2a human clinical trial. This trial was initiated by the ... in the midst of planning the details of a Phase 1 human clinical trial and expect to begin this trial, ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... 0% 12% n/a(5) n/a(5) human Genetic Therapies ELAPRASE ... sold in Euros and Pounds Sterling). human Genetic Therapies ELAPRASE - Hunter ... 427.2 580.2 -26% 68% human Genetic Therapies ("HGT") ELAPRASE ...

Microbia Names John McCarthy to Senior Management Team

... its line of natural carotenoid products for the human and animal food ingredient and nutritional ... for corporate strategic planning, finance, human resources, corporate communications and ... its line of natural carotenoid products for the human and animal food ingredient and nutritional ...

Micromet Closes $80.5 Million Public Offering of Common Stock

... is overexpressed in many solid tumors. Micromet's human monoclonal antibody adecatumumab (MT201) also ... the treatment of patients with cancer. MT203, a human antibody neutralizing the activity of ... trial in 2009 with Micromet's glycolipid-binding human antibody MT228 for the treatment of melanoma. ...

Human Genome Sciences Announces Closing of Public Offering

... ROCKVILLE, Md., Aug. 3 /PRNewswire-FirstCall/ -- human Genome Sciences, Inc. (Nasdaq: HGSI ) today ... solicitation of an offer to buy any securities of human Genome Sciences, Inc., nor shall there be any ... Department, 800-831-9146. About human Genome Sciences ...

Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab

... is overexpressed in many solid tumors. Micromet's human monoclonal antibody adecatumumab (MT201) also ... the treatment of patients with cancer. MT203, a human antibody neutralizing the activity of ... clinical trial with Micromet's glycolipid-binding human antibody MT228 for the treatment of melanoma. ...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors

... a substantial and increasing proportion of the human population as patients survive to older ages ... half-life of a protein once administered into the human body, the Company believes that the localized and ... 2008; 43: 440-449); and (4) Adenovirus Encoding human Platelet-Derived Growth Factor-B Delivered to ...

Micromet Announces Pricing of Public Offering of Common Stock

... is overexpressed in many solid tumors. Micromet's human monoclonal antibody adecatumumab (MT201) also ... the treatment of patients with cancer. MT203, a human antibody neutralizing the activity of ... trial in 2009 with Micromet's glycolipid-binding human antibody MT228 for the treatment of melanoma. ...

First genetically engineered malaria vaccine to enter human trials

... at least 35 million years of healthy, productive human life every year. Professor Alan Cowman, head of ... to multiply and lead to disease," he said. The human trials of the vaccine will take place at the ... manufacturing practice guidelines required for human clinical trials. ...

Micromet Announces Public Offering of Common Stock

... is overexpressed in many solid tumors. Micromet's human monoclonal antibody adecatumumab (MT201) also ... the treatment of patients with cancer. MT203, a human antibody neutralizing the activity of ... trial in 2009 with Micromet's glycolipid-binding human antibody MT228 for the treatment of melanoma. ...

Sanofi-aventis Announces Second Quarter 2009 Results

... 2009, the Committee for Medicinal Products for human Use (CHMP) of the EMEA issued a positive opinion ... basis and at constant exchange rates). human Vaccines Second-quarter consolidated net sales for the human Vaccines business were down 0.8% at euro 712 ...

Human Genome Sciences Announces Pricing of Public Offering of Common Stock

... Md., July 28 /PRNewswire-FirstCall/ -- human Genome Sciences, Inc. (Nasdaq: HGSI ) today ... solicitation of an offer to buy any securities of human Genome Sciences, Inc., nor shall there be any ... Department, 800-831-9146. About human Genome Sciences ...

Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications

... protein (PDGF-B), an important key in the human body's wound healing process. Sustained, ... be no assurance that the MATRIX study or other human clinical trials can be conducted and completed in ... of complex biologics and in the conduct of human clinical trials, including the timing, costs and ...

Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)

... About Denosumab Denosumab is a fully human monoclonal antibody that targets RANK Ligand and ... develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, ... - is committed to improving the quality of human life by enabling people to do more, feel better ...

Human Genome Sciences Announces Proposed Public Offering of Common Stock

... ROCKVILLE, Md., July 27 /PRNewswire/ -- human Genome Sciences, Inc. (Nasdaq: HGSI ) today ... solicitation of an offer to buy any securities of human Genome Sciences, Inc., nor shall there be any ... Department, 800-831-9146. About human Genome Sciences ...

NASA Extends Bioastronautics Contract With Wyle for Total Value of $976 Million

... Space Station, space shuttle, Constellation and human Research Programs. Wyle maintains readiness of ... habitability and environmental factors; human adaptation and countermeasures; space medicine; flight hardware development and human research activities. Option 2 is a ...

Micromet, Inc. to Host Conference Call and Webcast to Report Second Quarter 2009 Financial Results on August 6, 2009

... is overexpressed in many solid tumors. Micromet's human monoclonal antibody adecatumumab (MT201) also ... the treatment of patients with cancer. MT203, a human antibody neutralizing the activity of ... clinical trial with Micromet's glycolipid-binding human antibody MT228 for the treatment of melanoma. ...

PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group

... milestones in the development of our long-acting human growth hormone candidate that has the potential ... is currently developing long-acting versions of human growth hormone, interferon beta and ... as well as GLP-1. The company's long-acting human growth hormone drug candidate, which is expected ...

OMT announces a breakthrough in the development of a novel human antibody platform

... milestone in the development of OMT's novel human monoclonal antibody platform. "Creating a ... rat antibody expression is essential for human antibody expression in genetically engineered ... commercially available for the generation of human monoclonal antibodies, and many targets are ...

Video of EpiDerm Skin Irritation Test (SIT) Method Now Available

... alternative test method for determining the human skin irritation potential of chemicals, including ... Test (SIT) using the EpiDerm Reconstructed human Epidermal (RHE) Model", this peer-reviewed, ... world's largest independent producer of in vitro human epithelial tissue equivalents. With over 15 ...

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

... property portfolio, including the fully human antibody r84, which was discovered by Affitech ... to exceed $10 billion by 2015. The fully human and selective anti-VEGF monoclonal antibody, r84, ... inhibiting tumor growth in a number of models of human cancers, including a mouse model ...

Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International

... of the generation of iPS cells from normal human blood . "Dr. Yu strengthens CDI's ... a methodology whereby iPS cells were created from human skin cells without the integration of foreign DNA ... insertion of four genes. iPS cells are similar to human embryonic stem (hES) cells in their proliferative ...

Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government

... ROCKVILLE, Md., July 22 /PRNewswire-FirstCall/ -- human Genome Sciences, Inc. (Nasdaq: HGSI ) today ... that we are prepared as a nation to limit the human cost of such an attack should it ever occur." ... Response (ASPR), U.S. Department of Health and human Services (HHS). In April 2009, HGS fulfilled its ...

Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing

... approach based upon the implantation of primary human tumors in immune deficient mice followed by ... the biological characteristics of the original human tumor. Early studies suggest that unlike traditional xenografts, these Tumorgrafts closely reflect human cancer biology and their response to drugs is ...

Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing

... and purifying different cell types created from human pluripotent stem cells, including the company's first commercially available product line, human cardiomyocytes. Under the licensed technology, ... in 2004 by Dr. James Thomson , a pioneer in human embryonic stem cell research at the University of ...

Novel drug discovery tool could identify promising new therapies for Parkinson's disease

... cells are engineered to produce large amounts of human alpha-synuclein, they die. In their new study, ... notes that her lab and others have modeled many human diseases in yeast and in other kinds of cells. ... and other proteins that have been implicated in human Parkinson's disease are believed to play a role ...

Xanodyne Announces New Executive Team Members

... and Peter Wentworth, Senior Vice President, human Resources. Commenting on these ... has extensive experience within the field of human resources, including more than 25 years working ... Most recently he was Executive Vice President, human Resources at Adams Respiratory Therapeutics. ...

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

... issued by the U.S. Department of Health and human Services (HHS) to develop and deliver up to 25 ... clinical trials involving more than 750 healthy human subjects have been completed and showed that ... rPA anthrax vaccine Valortim(R) - a fully human monoclonal antibody for the prevention and ...

Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax

... Md., July 9 /PRNewswire-FirstCall/ -- human Genome Sciences, Inc. (Nasdaq: HGSI ) today ... showed the life-saving potential of the Company's human monoclonal antibody drug raxibacumab (ABthrax(TM)), as well as the results of human safety studies, which supported the use of ...

Cellular Dynamics International Reprograms Blood Cells into Stem Cells

... in the body, from very small volumes of ordinary human blood samples. This significant breakthrough ... accessible tissue source and we focused on stored human peripheral blood samples," said Chris ... stem cells and iPS cells generated from other human tissue sources, that they carry the same genetic ...

iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming

... . Dr. Daley's lab was among the first to produce human induced pluripotent stem cells and ... pathways to devise novel therapeutics for human cardiac disorders. Dr. Douglas Melton is ... drug candidates. iPierian plans to use precise human disease models to find new molecular targets and ...

GeoVax Labs, Inc. Announces Resignation of Director

... develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human ... GeoVax's AIDS vaccines have moved forward in human clinical trials conducted by the HIV Vaccine ... timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent ...

High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu

... CAPTURES pathogens by mimicking the sites on human cells to which they normally attach, then quickly ... sialic acid residue on the surface of the human cell membrane. The binding agent in the ... air, water, and from off surfaces - including the human skin, killing or inactivating them before they ...

Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models

... standard chemotherapy drugs in mouse models of human cancers. This research is being conducted under a ... recurrence in 50 % of animals bearing tumors of human glioblastoma multiforme (GBM), the most common ... be as effective as it is in animal models of human cancer. We believe that adding LB-1.2 may be a ...

Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement

... originally in March 2008 as a validation of CDI's human pluripotent stem cell technology, the expanded ... drug development and more accurately predict human physiological responses. "We are thrilled with the expansion of our Roche human cardiomyocyte program," said Robert Palay, CDI ...

Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research

... His work has had a remarkable impact on human health and truly embodies the efforts of the ... early 1980s, he developed genetically engineered human insulin, the first therapeutic derived from gene ... discovered gene with an oncogenic function in human cancer. In the early 1990s, Ullrich ...

Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa

... 25th annual meeting of the European Society of human Reproduction and Embryology (ESHRE) in Amsterdam, ... until triggering of final oocyte maturation by human chorionic gonadotropin (hCG). The primary ... onwards when required, to reach the criterion for human chorionic gonadotropin (hCG) administration (at ...
Other Contents
(Date:11/11/2014)... , Nov. 11, 2014  Forensicon, Inc., a ... is pleased to announce the promotion of Yaniv ... of Digital Forensics. In Schiff,s new role as Director, ... team of digital forensics examiners and provide leadership within ... Photo - http://photos.prnewswire.com/prnh/20141110/157719 Schiff ...
(Date:11/7/2014)... 6, 2014 Leading Biometric companies aim ... security revolutionizing online transactions.  Companies in focus today are: NXT-ID, ... BABA ), Google Inc. (NASDAQ: GOOG ... (NASDAQ: EBAY ) and MasterCard Inc. (NYSE: MA) ... NXTDW), a biometric authentication company focused on the growing mobile ...
(Date:11/6/2014)... Baltimore, MD, November 6, 2014 - Insilico Medicine, ... in aging and age related diseases announced a ... medicine of cancer, Champions Oncology, Inc (OTC: CSBR). ... genomics for personalized medicine, but Champions Oncology,s TumorGraft ... can validate the chemotherapy regimen experimentally generating vast ...
Breaking Biology News(10 mins):Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2
(Date:11/22/2014)... PITTSBURGH, PA (PRWEB) November 22, 2014 “Due ... cane,” said an inventor, from Gurnee, Ill. “While using the ... could be and I thought there needed to be a ... He invented the SPIKE BLOCK. , The SPIKE BLOCK offers ... doing so, it would help to reduce injuries and damage ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 In order to ... new promotion of cocktail party dresses. The business knows that ... in social occasions. , Now, the party dresses ... to 70% off. As the leading company in fashion industry, ... favorite outfit for every customer. So it always raises the ...
(Date:11/22/2014)... 2014 "My friend went in for ... the machine," said an inventor from Cambria Heights, N.Y. ... back a second time because the first results were ... developed the patent-pending MAMO EASY to offer a more ... saves the patient from the pain normally involved with ...
(Date:11/22/2014)... Australia (PRWEB) November 22, 2014 ... the declined slightly in 2009-10, due to a ... Product Manufacturing industry products amid the global ... the growing strength of Australian dairy manufacturers on ... for dairy products outweighed supply growth, primarily due ...
(Date:11/22/2014)... 22, 2014 The topic of B&D ... block retaining walls. The article states that, “While they give ... necessary steps that go into creating this powerful look.” , ... retaining wall is choosing which kind of block matches your ... B&D Rockeries says, “The two main options are concrete and ...
Breaking Medicine News(10 mins):Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2
Other TagsOther Tags